SHERMAN MATTHEW L (EVP & Chief Medical Officer) sold 2.5% of their position (2.44K shares) of DECIPHERA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $35.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/18/2024ACC: 0000950170-24-005393
Officer· EVP & Chief Medical Officer
Since Oct 2019
-2.44K
Net shares
Net seller
$35.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.44K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.44K
Price / share
$14.47
Trade value
$35.23K
% of position
2.5%
1/16/2024
96.51K→94.08K
Total
Net shares
−2.44K
Net value
-$35.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2024 | S · Sale | −2.44K | $14.47 | $35.23K | 2.5% | 96.51K | 94.08K |
| Total | −2.44K | -$35.23K | ||||||
Derivative Transactions0
No derivative transactions reported